The University of Texas Medical Branch · 4 months ago
MRI Technologist I - League City Campus (Fridays 7:00pm to 7:30am))
League City, TX
Full-time
Onsite
New Grad, Entry Level
0+ years expThe University of Texas Medical Branch is seeking an MRI Technologist I to work independently in performing routine MR procedures and providing assistance to physicians during diagnostic and special MR procedures. The role involves delivering exceptional patient care while adhering to established MR exam standards and guidelines for patient safety and customer service.
Responsibilities
Complete a variety of routine MR procedures to include common and specialty MR exams of moderate complexity
Provide direct assistance to physicians with all diagnostic and special MR procedures
Deliver exceptional patient care and adhere to MR exam standards and guidelines established by governing agencies to ensure optimal patient safety and customer service
Qualification
Required
Completion of MRI training program including UTMB MR Training Program or equivalent
0+ years of experience
American Heart Association (BLS)
American Registry of Radiologic Technologists (ARRT-MR) or American Registry of Magnetic Resonance Imaging Technologists (ARMRIT)
Must be MRI certified or MRI registry-eligible at the time of hire
Registry-eligible candidates are required to obtain MRI certification through the American Registry of Radiologic (ARRT) or an equivalent certifying (ex. ARMRIT) body within six (6) months of hire
Company
The University of Texas Medical Branch
The University of Texas Medical Branch is a component of the University of Texas System located in Galveston, Texas
10001+ employees
H1B Sponsorship
The University of Texas Medical Branch has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (73)
2024 (66)
2023 (52)
2022 (57)
2021 (49)
2020 (50)
Funding
Current Stage
Late StageTotal Funding
$35MKey Investors
National Institute of Allergy and Infectious Diseases
2024-09-13Grant
2019-04-09Grant· $35M
Leadership Team
Donna Sollenberger
EVP and CEO, Health System
Recent News
2025-10-30
Quetzal Therapeutics
2025-09-17
EIN Presswire
2025-08-25
Company data provided by crunchbase